Monday, December 11, 2017 5:09:51 PM
You said "similar". FDA does not test for "similarity". if Senhance testing was not equally as effective as DaVinci it would not have been cleared. There is no other truth except that one, no matter how much you wish it to be so.
Since you admit no wrong, you are claiming that the FDA cleared Senhance for "similarity".
I'm open to new info, just back it up with facts. Tell us then how the FDA testing and clearance process works for granting 501(k) clearance based on 'similarity'. You do know enough about it based on your claims, to speak on it intelligently correct?
You also are claiming i suggest a BO or partnership from ISRG. 100% false fact / I never said that. I've posted more than once that I do not think it is a good idea and is unlikely a this time.
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM